If you’ve ever booked a trip online using a site such as Kayak or Expedia, you’ve seen something of the future of healthcare computing.

The repeated impacts experienced in one season of playing high school football can do significant damage to an athlete’s brain, according to a recent study published by the Journal of Neurotrauma.

Sunnyvale, Calif. – April 19, 2016 – Molecular Devices, LLC, a leader in protein and cell biology technologies, today announced the launch of its ImageXpress® Micro 4 High-Content Imaging System and revolutionary 3D image analysis capability in the latest version of MetaXpress® High-Content Image Acquisition and Analysis Software. For scientists conducting basic research or high-throughput screening, the ImageXpress System is a premiere, integrated and scalable toolset for optimal 3D image acquisition and analysis.

Knoxville, TN, UNITED STATES, March 18, 2016– ABT Molecular Imaging has partnered with a world-renowned oncology group to install the BG-75 Biomarker Generator System in  The Republic of Cyprus.  The BG-75 integrates a compact cyclotron, micro-chemistry, and automated quality control, to provide on-demand F-18 FDG production in one seamless solution to support the implementation of PET/CT.

Radiology and biochemistry researchers at UC-San Diego say they have figured out how to dissolve and encapsulate metals inside fluorine-based droplets, in the process synthesizing a new cell-labeling probe that can, in in effect, “greatly amp up the MRI signal” for potential use in in immunotherapy, inflammation treatment and other emerging clinical applications. 

Want to know which specific hereditary ailments you, and you alone, are susceptible to? All of them? 

A new advancement in real-time visualization of body tissues using molecular imaging probes could significantly increase early detection and treatment capabilities of cancer and other diseases, according to results of a study published online in Nature Communications.

The FDA has issued a new draft guidance intended to assist FDA staff and those in the healthcare industry with submitting investigational device exemption (IDE) applications to conduct clinical trials for neurological medical devices.